Results 171 to 180 of about 1,035,264 (338)

P1651: IMPACT OF NEUTROPHIL EXTRACELLULAR TRAPS (NETS) AND MACROPHAGE ACTIVATION IN THE THROMBOTIC EVENTS IN COVID-19 PATIENTS

open access: yesHemaSphere, 2023
Irene Serrano-Gonzalo   +8 more
doaj   +1 more source

Seroprevalencia y factores de riego de neosporosis bovina en una finca en Risaralda, 2018 [PDF]

open access: yes, 2019
La neosporosis es una enfermedad parasitaria causada por Neospora caninum, la presencia de esta enfermedad en el ganado bovino genera grandes pérdidas económicas debido a que produce abortos entre el tercer y noveno mes de gestación.
Sánchez Ospina, Angie Catalina
core  

Enfermedades infecciosas: cólera

open access: yes, 2007
Este artículo basado en fotogramas se basa en la enfermedad infecciosa llamada cólera.
Garc?a S?nchez, Jos? El?as   +2 more
openaire   +1 more source

Intervention and Strategies to Prevent Workplace Violence From Patients and Visitors Against Nurses: An Integrative Review

open access: yesJournal of Advanced Nursing, EarlyView.
ABSTRACT Aim To synthesise the existing literature on effective interventions aligned with the 2015 U.S. Occupational Safety and Health Administration guidelines to address workplace violence against nurses. Design An integrative review. Methods PubMed, Embase, CINAH, and PsycINFO databases were searched for articles published between 2010 and 2023 ...
Islam Qasem, Gordon L. Gillespie
wiley   +1 more source

Therapeutic advances in pruritus as a model of personalized medicine

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Recent advances in itch biology reveal that chronic pruritus arises from distinct neuroimmune pathways driven by cytokines, JAK, BTK and GPCRs. Targeted biologics and small molecule inhibitors such as dupilumab, nemolizumab, remibrutinib and JAK inhibitors precisely modulate these pathways, leading to a new era of personalized therapeutics in pruritus.
Kelsey Auyeung   +2 more
wiley   +1 more source

Frailty and Health Outcomes in People 65 Years or Older Living With Dementia: A Systematic Review of the Literature

open access: yesJournal of the American Geriatrics Society, EarlyView.
ABSTRACT Introduction Although frailty is considered a potentially modifiable risk factor for dementia, its influence on health outcomes in individuals with established dementia remains unclear. This study aims to systematize the current evidence to understand the impact of frailty on the development of adverse outcomes in older adults with dementia ...
Miguel German Borda   +11 more
wiley   +1 more source

COVID-19 y enfermedad cardiovascular

open access: yesRevista Colombiana de Cardiología, 2020
Juan Francisco Figueroa Triana   +4 more
semanticscholar   +1 more source

Older Age Is Associated With Long‐Term Retention in Buprenorphine Treatment for Opioid Use Disorder

open access: yesJournal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Opioid use disorder (OUD) among older adults is a fast‐growing public health problem. However, little is known about treatment outcomes among older adults in office‐based buprenorphine programs. Thus, our objective was to examine how age is associated with buprenorphine treatment outcomes among adults with OUD who initiate ...
Justina L. Groeger   +11 more
wiley   +1 more source

Prevalence of Mental Health problems in sentenced men in prisons from Andalucía (Spain)

open access: yesRevista Española de Sanidad Penitenciaria
Objectives: To estimate the prevalence of different mental health problems in men serving prison sentences in Andalusia. Methods: Descriptive, cross-sectional study of a random sample of 472 men interned in two prisons located in Andalusia.
M. López   +3 more
doaj  

PLATELET ANTIAGGREGANTS: MECHANISMS OF ACTION AND USE ASOCIED RISKS

open access: yesVitae, 2009
Cardiovascular diseases are the main cause of death in the world. Next to efforts to reduce the cardiovascular risk factors, several drugs are resorted to decrease morbimortality associated to these diseases: antihypertensive, antidiabetic, hypolipemiant
Iván F. PALOMO G   +4 more
doaj  

Home - About - Disclaimer - Privacy